[go: up one dir, main page]

AU2002365216A1 - Therapeutic polypeptides, nucleic acids encoding same, and methods of use - Google Patents

Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Info

Publication number
AU2002365216A1
AU2002365216A1 AU2002365216A AU2002365216A AU2002365216A1 AU 2002365216 A1 AU2002365216 A1 AU 2002365216A1 AU 2002365216 A AU2002365216 A AU 2002365216A AU 2002365216 A AU2002365216 A AU 2002365216A AU 2002365216 A1 AU2002365216 A1 AU 2002365216A1
Authority
AU
Australia
Prior art keywords
methods
nucleic acids
acids encoding
encoding same
therapeutic polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002365216A
Other languages
English (en)
Other versions
AU2002365216A8 (en
Inventor
John P. Ii Alsobrook
David W. Anderson
Ferenc L. Boldog
Catherine E. Burgess
Stacie J. Casman
Shlomit R. Edinger
Karen Ellerman
Valerie L. Gerlach
Linda Gorman
Xiaojia Guo
Tord Hjalt
Weizhen Ji
Ramesh Kekuda
Mario W. Leite
Denise M. Lepley
Li Li
John R. Macdougall
Kumud Majumder
Uriel M. Malyankar
Charles E. Miller
Muralidhara Padigaru
Meera Patturajan
Carol E. A. Pena
Luca Rastelli
Daniel K. Rieger
Richard A. Shimkets
Glennda Smithson
Kimberley A. Spytek
David J. Stone
Corine A. M. Vernet
Edward Z. Voss
Adam R. Wolenc
Bryan D. Zerhusen
Mei Zhong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CuraGen Corp
Original Assignee
CuraGen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/210,172 external-priority patent/US20040043928A1/en
Application filed by CuraGen Corp filed Critical CuraGen Corp
Publication of AU2002365216A1 publication Critical patent/AU2002365216A1/en
Publication of AU2002365216A8 publication Critical patent/AU2002365216A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2002365216A 2001-01-23 2002-08-02 Therapeutic polypeptides, nucleic acids encoding same, and methods of use Abandoned AU2002365216A1 (en)

Applications Claiming Priority (54)

Application Number Priority Date Filing Date Title
US26360401P 2001-01-23 2001-01-23
US30950101P 2001-08-02 2001-08-02
US60/309,501 2001-08-02
US31029101P 2001-08-03 2001-08-03
US60/310,291 2001-08-03
US31054401P 2001-08-07 2001-08-07
US60/310,544 2001-08-07
US31095101P 2001-08-08 2001-08-08
US60/310,951 2001-08-08
US31129201P 2001-08-09 2001-08-09
US60/311,292 2001-08-09
US31197901P 2001-08-13 2001-08-13
US60/311,979 2001-08-13
US31289201P 2001-08-16 2001-08-16
US60/312,892 2001-08-16
US31341501P 2001-08-17 2001-08-17
US31320101P 2001-08-17 2001-08-17
US60/313,415 2001-08-17
US60/313,201 2001-08-17
US31364301P 2001-08-20 2001-08-20
US31370201P 2001-08-20 2001-08-20
US60/313,702 2001-08-20
US60/313,643 2001-08-20
US31403101P 2001-08-21 2001-08-21
US60/314,031 2001-08-21
US31446601P 2001-08-23 2001-08-23
US60/314,466 2001-08-23
US31540301P 2001-08-28 2001-08-28
US60/315,403 2001-08-28
US31585301P 2001-08-29 2001-08-29
US60/315,853 2001-08-29
US32271601P 2001-09-17 2001-09-17
US60/322,716 2001-09-17
US32399401P 2001-09-21 2001-09-21
US60/323,994 2001-09-21
US34023301P 2001-12-14 2001-12-14
US60/340,233 2001-12-14
US35459102P 2002-02-05 2002-02-05
US60/354,591 2002-02-05
US36547802P 2002-03-19 2002-03-19
US60/365,478 2002-03-19
US37381402P 2002-04-19 2002-04-19
US37398902P 2002-04-19 2002-04-19
US37382502P 2002-04-19 2002-04-19
US60/373,989 2002-04-19
US60/373,825 2002-04-19
US60/373,814 2002-04-19
US37463202P 2002-04-23 2002-04-23
US60/374,632 2002-04-23
US38697102P 2002-06-07 2002-06-07
US60/386,971 2002-06-07
US10/210,172 US20040043928A1 (en) 2001-08-02 2002-08-01 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US10/210,172 2002-08-01
PCT/US2002/024483 WO2003064589A2 (fr) 2001-01-23 2002-08-02 Polypeptides therapeutiques, acides nucleiques les codant et leurs methodes d'utilisation

Publications (2)

Publication Number Publication Date
AU2002365216A1 true AU2002365216A1 (en) 2003-09-02
AU2002365216A8 AU2002365216A8 (en) 2005-11-17

Family

ID=27671413

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002365216A Abandoned AU2002365216A1 (en) 2001-01-23 2002-08-02 Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Country Status (2)

Country Link
AU (1) AU2002365216A1 (fr)
WO (1) WO2003064589A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
US20140302034A1 (en) 2010-12-08 2014-10-09 Stem Centrx, Inc. Novel modulators and methods of use
EP3065780A1 (fr) 2013-11-04 2016-09-14 Pfizer Inc. Conjugués anticorps anti-efna4-médicament

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593104B1 (en) * 1999-02-12 2003-07-15 University Of Iowa Research Foundation Macular degeneration diagnostics and therapeutics

Also Published As

Publication number Publication date
WO2003064589A2 (fr) 2003-08-07
WO2003064589A3 (fr) 2005-08-04
AU2002365216A8 (en) 2005-11-17

Similar Documents

Publication Publication Date Title
WO2003023008A8 (fr) Polypeptides therapeutiques, acides nucleiques les codant, et modalites d'emploi correspondantes
EP1576169A4 (fr) Polypeptides therapeutiques, acides nucleiques codant pour ceux-ci et methodes d'utilisation associees
EP1487864A4 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et methodes d'utilisation associees
AU2002356534A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2001296333A1 (en) Paad domain-containing polypeptides, encoding nucleic acids, and methods of use
EP1446419A4 (fr) Polypeptides therapeutiques, acides nucleiques codant ceux-ci et procedes d'utilisation
WO2003040330A8 (fr) Polypeptides therapeutiques, acides nucleiques les codant et procedes d'utilisation correspondant
AU2003217956A1 (en) Therapeutic polypeptides, nucleic acids encoding same and methods of use
EP1401858A4 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation
EP1432726A4 (fr) Polypeptides therapeutiques, acides nucleiques codant ces derniers et methodes d'utilisation correspondantes
WO2003083039A8 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides, et leurs procedes d'utilisation
EP1532238A4 (fr) Polypeptides therapeutiques, acides nucleiques les codant et procedes d'utilisation correspondant
AU2002334781A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
EP1549671A4 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et methodes d'utilisation associees
EP1399537A4 (fr) Polypeptides therapeutiques, acides nucleiques les codant, et procedes d'utilisation
AU2002309646A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
AU2002365216A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2002303232A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
WO2003023002A9 (fr) Nouvelles proteines humaines, polynucleotides codant ces proteines et procedes d'utilisation associes
WO2003060149A9 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation
AU2003304034A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2003270424A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2002360485A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2002322405A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1504026A4 (fr) Polypeptides therapeutiques, acides nucleiques codant ceux-ci et procedes d'utilisation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase